Cells

Search Results for: Cells

(syswasser) fraunhofer clusters of excellence advanced photon sources circular plastics economy cognitive internet technologies immune-mediated diseases integrated energy systems programmable materials cooperation research fab microelectronics germany (fmd) fraunhofer research factory for battery cells

processes and products futuream – next generation additive manufacturing go beyond – digital printing and laser processes mmed icin – digital patient model as a basis for personalised and cost-optimised treatment ml p – machine learning for production manitu – materials for sustainable tandem solar cells...

https://www.fraunhofer.de/en/press/research-news/2020/april/mass-production-of-covid-19-test-systems.html

-based biotechnology and regenerative medicine start-up has developed a revolutionary technology: humacyte grows blood vessels from donated smooth muscle cells in a bioreactor. dr. jeffrey lawson, ceo of humacyte and a vascular surgeon, describes the benefits for dialysis patients: "because our human

acellular vessel no longer contains human cells, this vessel can be implanted in the patient without the risk of rejection." compared to synthetic transplants, the technology is expected to result in fewer complications, infections, and fewer surgical procedures....

https://www.freseniusmedicalcare.com/en/media/insights/company-features/regenerative-medicine-the-road-to-healing/

cell technology. at t-cira, several novel research projects focusing on the creation of medical applications of ipsc are underway, led by nine principal investigators (pi) with co-principal investigators (co-pi) from takeda. cell therapy development of a novel immunotherapy using ipsc-derived immune cells

drug discovery for intractable muscular disease using patient-derived ipscs hidetoshi sakurai (pi, cira) ryuichi tozawa (co-pi, takeda) tomoya uchimura(sub pi, cira) masahiro oka(sub pi, takeda) tatsuo oikawa(sub pi, takeda) development of therapeutic agents for rare hereditary diseases using ips cells...

https://www.takeda.com/what-we-do/t-cira/members/

cell technology. at t-cira, several novel research projects focusing on the creation of medical applications of ipsc are underway, led by nine principal investigators (pi) with co-principal investigators (co-pi) from takeda. cell therapy development of a novel immunotherapy using ipsc-derived immune cells

drug discovery for intractable muscular disease using patient-derived ipscs hidetoshi sakurai (pi, cira) ryuichi tozawa (co-pi, takeda) tomoya uchimura(sub pi, cira) masahiro oka(sub pi, takeda) tatsuo oikawa(sub pi, takeda) development of therapeutic agents for rare hereditary diseases using ips cells...

http://www.takeda.com.pl/what-we-do/t-cira/members/

cell technology. at t-cira, several novel research projects focusing on the creation of medical applications of ipsc are underway, led by nine principal investigators (pi) with co-principal investigators (co-pi) from takeda. cell therapy development of a novel immunotherapy using ipsc-derived immune cells

drug discovery for intractable muscular disease using patient-derived ipscs hidetoshi sakurai (pi, cira) ryuichi tozawa (co-pi, takeda) tomoya uchimura(sub pi, cira) masahiro oka(sub pi, takeda) tatsuo oikawa(sub pi, takeda) development of therapeutic agents for rare hereditary diseases using ips cells...

http://www.takeda.com.pl/what-we-do/t-cira/members/

cell technology. at t-cira, several novel research projects focusing on the creation of medical applications of ipsc are underway, led by nine principal investigators (pi) with co-principal investigators (co-pi) from takeda. cell therapy development of a novel immunotherapy using ipsc-derived immune cells

drug discovery for intractable muscular disease using patient-derived ipscs hidetoshi sakurai (pi, cira) ryuichi tozawa (co-pi, takeda) tomoya uchimura(sub pi, cira) masahiro oka(sub pi, takeda) tatsuo oikawa(sub pi, takeda) development of therapeutic agents for rare hereditary diseases using ips cells...

https://www.takeda.com/what-we-do/t-cira/members/

cell technology. at t-cira, several novel research projects focusing on the creation of medical applications of ipsc are underway, led by nine principal investigators (pi) with co-principal investigators (co-pi) from takeda. cell therapy development of a novel immunotherapy using ipsc-derived immune cells

drug discovery for intractable muscular disease using patient-derived ipscs hidetoshi sakurai (pi, cira) ryuichi tozawa (co-pi, takeda) tomoya uchimura(sub pi, cira) masahiro oka(sub pi, takeda) tatsuo oikawa(sub pi, takeda) development of therapeutic agents for rare hereditary diseases using ips cells...

https://www.takeda.com/what-we-do/t-cira/members/

effect of mycobacterium leprae on neurotrophins expression in human schwann cells and mouse sciatic nerves. | infolep skip to main content top menu infolep about infolep select language english afrikaans albanian arabic armenian azerbaijani basque belarusian bengali bosnian bulgarian catalan cebuano

norwegian persian polish portuguese punjabi romanian russian serbian slovak slovenian somali spanish swahili swedish tamil telugu thai turkish ukrainian urdu vietnamese welsh yiddish yoruba zulu apply back to search publication effect of mycobacterium leprae on neurotrophins expression in human schwann cells...

https://www.leprosy-information.org/resource/effect-mycobacterium-leprae-neurotrophins-expression-human-schwann-cells-and-mouse-sciatic

, or apcs. apcs then "present" pieces of the allergen to other immune system cells. in most people, these other immune cells (th cells, or t helper cells) "check" and usually ignore the allergen molecules. in asthmatics, however, these cells transform into a different type of cell (th ), for reasons

that are not well understood. the resultant th cells activate an important arm of the immune system, known as the humoral immune system . the humoral immune system produces antibodies against the inhaled allergen. later, when an asthmatic inhales the same allergen, these antibodies "recognize" it and...

https://www.newworldencyclopedia.org/entry/Asthma

outer membrane take quiz lesson - structure of the nucleus: nucleolus, nuclear membrane, and nuclear pores take quiz lesson - the fluid mosaic model of the cell membrane take quiz lesson - how a phospholipid bilayer is both hydrophobic and hydrophilic take quiz lesson - active & passive transport in cells

cytoskeleton: microtubules and microfilaments take quiz lesson - differences between aerobic vs. anaerobic respiration take quiz go to chapter texes life science: cell biology practice test: texes life science: cell biology week {{::cp.getgoalweekfortopic( , )}} ch . texes life science: prokaryotic cells...

https://study.com/academy/course/texes-life-science-7-12-practice-and-study-guide.html